The FDA granted Fast Track designation to HTX-001, an investigational lncRNA-targeting antisense therapy for nonobstructive hypertrophic cardiomyopathy.

A consensus statement urges the adoption of enhanced radiation protection devices to reduce occupational risks for health care workers.

A new study introduces the Advocacy-Adjustment Dyad, a clinical framework designed to help nurses support older adults with cancer in the intensive care unit.

Subclinical lung health impairment in young adulthood may provide evidence of an intermediate phenotype in the pathogenesis of heart failure later in life.

Nearly 1 in 4 US workers say they are staying in a job they do not want for the health insurance, according to a survey.

Neighborhood-level social determinants of health affect cardiac rehabilitation referral rates for patients with myocardial infarction.

Discover how abnormal sleep duration and insomnia are linked to an increased risk for cardiometabolic disease and mortality in adults.

The FDA has approved Furoscix ReadyFlow, an 80 mg/mL subcutaneous furosemide autoinjector delivering IV-equivalent diuresis in under 10 seconds for adult edema in heart failure or CKD.

Semaglutide improves kidney outcomes and survival in patients with type 2 diabetes and chronic kidney disease, regardless of baseline CVD risk.

Researchers compared the safety and efficacy profiles of oral P2Y12 inhibitors among patients receiving percutaneous coronary intervention.

The American Heart Association issued a scientific statement on deprescribing for patients with cardiovascular disease and polypharmacy.

Dr Bond and Dr Lau stated that hormone therapy may be appropriate when a woman is younger than 60 years or within 10 years of ...